스토마 케어 및 오스토미 케어시장 2026년까지

출판: MarketsandMarkets(마켓츠앤드마켓츠)출판년월:2022년01월

・제품 가방 수술 타입 (일레오스토미, 인공 항문, 인공 방광), 시스템 (1, 2 개), 유용성 (배수 가능, 폐쇄), 형태 (플랫, 볼록), 부속 제품(파우더, 방취제), 최종 사용자, 지역별 – 2026년까지의 세계 예측

Stoma/Ostomy Care Market by Product (Bags (Surgery Type (Ileostomy, Colostomy, Urostomy), System (One, Two-Piece), Usability (Drainable, Closed), Shape (Flat, Convex)), Accessories (Powder, Deodorant)), End User and Region – Global Forecast to 2026

폐이지수 197
도표수 143
가격
Single User License USD6,780
Multi User License(5명) USD8,150
Corporate(site) License USD9,780
Enterprise License USD11,000
구성 영문조사보고서

리포트목차보기    견적・문의・의뢰로 이동    구입안내

Sample Request

The global Stoma/Ostomy Care Market is expected to reach USD 3.2 billion by 2026 from an estimated USD 2.6 billion in 2021, at a CAGR of 4.3% from 2021 to 2026.
세계 스토마 케어 / 오스토미 케어 시장은 2021년부터 2026년까지 CAGR 4.3%로 2021년 26억 달러에서 2026년 32억 달러에 이를 것으로 예상됩니다.

Ostomy is a surgical procedure that involves the removal of diseased portions of the gastrointestinal or urinary system, creating an opening in the abdominal wall that results in the external diversion of feces and urine. An ostomy may be permanent or temporary, and each procedure results in a stoma, which is the end of the small or large intestine that can be seen protruding through the abdominal wall. The market scope includes ostomy bags/pouches and accessories utilized by ostomates or patients undergoing colostomy, ileostomy, and urostomy.

The increasing target patient population, rising geriatric population, a growing number of awareness programs, and product development efforts are some factors driving the growth of this market. Colorectal cancer, bladder cancer, and inflammatory bowel disease are the major conditions necessitating ostomy surgeries. The treatment of colorectal cancer and inflammatory bowel disease (IBD) involves the surgical removal of the malignant tumor/part of the intestine. In some cases, the surgical opening is made through the abdomen to provide a new pathway for waste elimination, commonly referred to as an ostomy. A surge in the incidence of these conditions, coupled with the growing exposure to risk factors (such as changing food habits and growing use of antibiotics in childhood), has increased the number of ostomy surgeries globally. Some of the major statistics related to the incidence of target indications are mentioned below:
 According to GLOBOCAN 2020, colon and rectal cancers are the fifth and eighth most common cancers globally.
 Approximately 550,000 new urinary bladder cancer cases were diagnosed worldwide in 2018 (Source: World Cancer Research Fund International).
 Around 6.8 million cases of inflammatory bowel disease were diagnosed in 2017 globally. The prevalence rate of IBD increased from 79·5 per 100,000 population in 1990 to 84·3 per 100,000 population in 2017. The highest prevalence of IBD was observed in the US (464·5 per 100,000 population), followed by the UK (449·6 per 100,000 population) (Source: Global Burden of Disease Study 2017).

“Colostomy segment accounted for the largest share of global stoma/ostomy care market in 2020”
Based on surgery, the stoma/ostomy care market is segmented into ileostomy, colostomy, and urostomy. Colostomy is the most common type of surgical procedure performed globally. The rising incidence of colon cancer, stomach cancer, and IBD in developed and developing countries, coupled with the favorable reimbursement scenario in developed countries, is supporting the growth of this segment.
Colostomy dominates the stoma/ostomy care market, by surgery type. However, ileostomy is expected to grow at the highest rate over the forecast period. Colostomy segment accounted for the largest share of 43.33 % of the market and it is projected that it would reach to USD 1,380.4 million by 2026 from USD 1,121.5 million in 2021, at a CAGR of 4.2%.
A colostomy is a surgically created opening in the abdomen to bring the small part of the colon (large intestine) to the body surface, typically performed when a portion of the colon or the rectum of the patient is removed. This allows for the remaining part of the colon to be brought to the abdominal wall. Colostomy can be temporary or permanent, with permanent being more common.
Also, for instance in June 2021, Welland Medical Limited launched a new innovative ostomy bag under the brand name Aurum Plus. It is available in both closed and drainable types.

“Hospitals and Specialty clinics segment accounted for the largest market share of the stoma/ostomy care market based on end user in 2020”
Based on end users, the stoma/ostomy care market is segmented into hospitals & specialty clinics, home care settings, and ambulatory surgical centers. The hospitals & specialty clinics segment accounted for the largest share of the stoma/ostomy care market in 2020.
The growing demand for home healthcare services is an important trend in the end-user market. Moreover, patients who have undergone colostomy, ileostomy, and urostomy surgeries often require ostomy care till the reversal of the surgery or during their lifetime. This has increased the demand for home care services. In recent times, ambulatory surgical centers have emerged as important end users in the stoma/ostomy care market.
This segment includes large and small hospitals, community hospitals, outpatient units, and hospitals associated with medical institutions, universities, and cancer clinics. The hospitals & specialty clinics segment accounted for 79.0% of the stoma/ostomy care market in 2020. The rising target patient population and the favorable reimbursement scenario in most developed countries are the major factors supporting the growth of this segment. For instance, according to a study by the University of Birmingham (2017), the prevalence of ulcerative colitis (UC) increased from 380 per 100,000 population in 2000 to 640 per 100,000 population in 2016. In China, stomach cancer and bladder cancer incidence were expected to increase from 454,000 and 62,400 to 523,000 and 71,500, respectively, from 2015 to 2020.
Hospitals and key players operating in this market are collaborating to provide training to healthcare professionals and nurses about ostomy care to increase the success rate associated with the procedure and reduce postoperative complications. This factor is expected to increase the number of patients undergoing colostomy, ileostomy, and urostomy procedures, further supporting the growth of this segment. For instance, the Wound, Ostomy and Continence Nurses Society (US) has designed a program on ‘Access to Wound, Ostomy, and Continence (WOC) Supplies.’ The program is aimed to protect and enhance patients’ access to WOC supplies.
In addition, Coloplast, a leading player in this market, has a program called ‘Access to Healthcare’ under which the company partners with various healthcare organizations and hospitals, such as the World Council of Enterostomal Therapists (WCET) and the China Nursing Association. Through this collaborative activity, the company provides training to healthcare professionals.

“Ostomy Bag segment accounted for the largest market share of the stoma/ostomy care market based on product type in 2020”

Based on product, the stoma/ostomy care market is segmented into two broad categories—ostomy bags and accessories. The ostomy bags segment accounted for the largest share of the stoma/ostomy care market in 2020. The large share of this segment is attributed to their high usage and low cost. However, the accessories segment is expected to grow at the highest CAGR of during the forecast period. Ostomy bags hold the largest share of the products market due to the growing number of patients suffering from target diseases (such as colorectal cancer and bladder cancer). Moreover, the efficient reimbursement system in developed countries and rising awareness aid market growth.

“The APAC market, by region, to register highest growth rate in the forecast period”
The Asia Pacific market is segmented into Japan, China, India, South Korea, Australia, and the Rest of Asia Pacific. In 2020, the APAC accounted for 23.84% of the stoma/ostomy care market and grow at the highest CAGR of 5.1%. Awareness initiatives by public and private organizations, a large patient population base for target diseases, and the rising geriatric population are the key factors driving the market growth. In addition, many market players are focusing on strengthening their distribution networks in APAC markets to capitalize on the growth opportunities in this region.
However, the limited availability of medical reimbursements, reluctance among patients to adopt technologically advanced products, and a lack of awareness among patients and healthcare professionals regarding the effective treatment methodologies for stoma care are expected to restrain market growth in the APAC.

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–25%, Tier 2–37%, and Tier 3– 38%
• By Designation: C-level–34%, Director-level–35%, and Others–31%
• By Region: North America–24%, Europe–32%, Asia Pacific–28%, Latin America–10%, and the Middle East & Africa–6%

Prominent players in the stoma/ostomy care market include Coloplast Corp (Denmark), Hollister Incorporated (US), B. Braun Melsungen AG (Germany), ConvaTec Inc. (England), Salts Healthcare (UK), Welland Medical Limited (UK), and Flexicare Group Limited (UK),

Research Coverage

This report studies the stoma/ostomy care market based on product type, surgery type, end user and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:
 Market Penetration: Comprehensive information on the product portfolios offered by the top players in the stoma/ostomy care market
 Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the stoma/ostomy care market
 Market Development: Comprehensive information on lucrative emerging regions
 Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the stoma/ostomy care market
 Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.


목차

1 INTRODUCTION 22
1.1 OBJECTIVES OF THE STUDY 22
1.2 MARKET DEFINITION 22
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 23
1.3 MARKET SCOPE 23
FIGURE 1 MARKETS COVERED 23
1.3.1 YEARS CONSIDERED FOR THE STUDY 24
1.4 CURRENCY USED FOR THE STUDY 24
TABLE 1 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD 24
1.5 KEY MARKET STAKEHOLDERS 25
1.6 SUMMARY OF CHANGES 25
2 RESEARCH METHODOLOGY 27
2.1 RESEARCH DATA 27
FIGURE 2 RESEARCH DESIGN 27
2.1.1 SECONDARY DATA 28
2.1.1.1 Indicative list of secondary sources 29
2.1.2 PRIMARY DATA 30
2.1.2.1 Breakdown of primaries 31
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 31
2.2 MARKET SIZE ESTIMATION METHODOLOGY 31
FIGURE 4 REVENUE MAPPING-BASED MARKET ESTIMATION 32
2.3 MARKET SIZE ESTIMATION 32
2.3.1 PRODUCT-BASED MARKET ESTIMATION 32
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE-BASED APPROACH 33
2.3.2 EPIDEMIOLOGY-BASED MARKET SIZE ESTIMATION 34
2.3.3 PRIMARY RESEARCH VALIDATION 35
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 36
FIGURE 6 DATA TRIANGULATION METHODOLOGY 36
2.5 RESEARCH LIMITATIONS AND ASSUMPTIONS 37
2.5.1 ASSUMPTIONS FOR THE STUDY 37
2.6 RESEARCH LIMITATIONS 37

3 EXECUTIVE SUMMARY 38
FIGURE 7 STOMA/OSTOMY CARE MARKET, BY PRODUCT,
2020 VS. 2025 (USD MILLION) 38
FIGURE 8 STOMA/OSTOMY CARE MARKET, BY SURGERY TYPE,
2020 VS. 2025 (USD MILLION) 39
FIGURE 9 STOMA/OSTOMY CARE MARKET, BY END USER,
2020 VS. 2025 (USD MILLION) 40
FIGURE 10 OSTOMY ACCESSORIES MARKET SHARE, BY TYPE, 2020 VS. 2025 40
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE STOMA/OSTOMY CARE MARKET 41
4 PREMIUM INSIGHTS 42
4.1 STOMA/OSTOMY CARE MARKET OVERVIEW 42
FIGURE 12 GROWING TARGET PATIENT POPULATION IS DRIVING THE GROWTH OF THE STOMA/OSTOMY CARE MARKET 42
4.2 STOMA/OSTOMY CARE MARKET SEGMENTAL OVERVIEW, 2020 (USD MILLION) 43
FIGURE 13 HOSPITALS & SPECIALITY CLINICS TO DOMINATE THE MARKET,
BY END USER, IN 2020 43
4.3 EUROPE: STOMA/OSTOMY CARE MARKET, BY SURGERY TYPE,
2021 VS. 2026 (USD MILLION) 44
FIGURE 14 COLOSTOMY SEGMENT DOMINATES THE EUROPEAN STOMA/
OSTOMY CARE MARKET 44
4.4 GEOGRAPHIC SNAPSHOT OF THE STOMA/OSTOMY CARE MARKET 44
FIGURE 15 ASIA PACIFIC IS THE FASTEST-GROWING MARKET FOR OSTOMY PRODUCTS 44
5 MARKET OVERVIEW 45
5.1 INTRODUCTION 45
5.2 MARKET DYNAMICS 45
FIGURE 16 STOMA/OSTOMY CARE MARKET: DRIVERS, RESTRAINTS,
OPPORTUNITIES, AND CHALLENGES 45
5.2.1 DRIVERS 46
5.2.1.1 Growing target patient population and prevalence of inflammatory bowel diseases 46
FIGURE 17 NUMBER OF NEW COLORECTAL CANCER CASES, BY COUNTRY (2020) 46
5.2.1.2 Rising geriatric population 47
FIGURE 18 NUMBER OF COLORECTAL CANCER CASES, BY AGE (2020) 47
FIGURE 19 NUMBER OF BLADDER CANCER CASES, BY AGE (2020) 48
5.2.1.3 Technological advancements 48
5.2.1.4 Favorable reimbursement system in developed countries 49
5.2.1.5 Awareness programs 49
5.2.2 RESTRAINTS 50
5.2.2.1 Complications associated with ostomy 50
5.2.2.2 Growing adoption of alternative treatments 50
5.2.2.3 Discomfort and other issues associated with ostomy bags 51

5.2.3 OPPORTUNITIES 51
5.2.3.1 Growth opportunities offered by emerging markets 51
5.2.3.2 Growing internet usage for online sales 51
5.2.3.3 Growing medical tourism in Asian countries 52
5.2.4 CHALLENGES 52
5.2.4.1 Disparities in reimbursement for ostomy supplies in emerging countries 52
5.3 REGULATORY LANDSCAPE 52
TABLE 2 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING THE STOMA/OSTOMY CARE MARKET 52
5.3.1 NORTH AMERICA 53
5.3.1.1 US 53
TABLE 3 CLASSIFICATION OF MEDICAL DEVICES BY US FDA 53
5.3.1.2 Canada 54
5.3.2 EUROPE 54
5.3.3 ASIA PACIFIC 54
5.3.3.1 India 54
5.3.3.2 China 55
TABLE 4 NMPA MEDICAL DEVICE CLASSIFICATION 55
5.3.3.3 Japan 55
TABLE 5 CLASSIFICATION OF MEDICAL DEVICES BY PMDA 56
5.4 COVID-19 IMPACT ON THE STOMA/OSTOMY CARE MARKET 56
5.5 REIMBURSEMENT SCENARIO 57
TABLE 6 NUMBER OF SUPPLIES COVERED BY MEDICARE 2021 57
5.6 PATENT ANALYSIS 59
5.6.1 PATENTS GRANTED FOR OSTOMY CARE 59
FIGURE 20 PATENTS GRANTED FOR OSTOMY CARE
(JANUARY 2011 TO NOVEMBER 2021) 59
5.6.2 JURISDICTION AND TOP APPLICANT ANALYSIS 60
TABLE 7 TOP 20 PATENT OWNERS FOR OSTOMY CARE
(JANUARY 2011 TO NOVEMBER 2021) 60
FIGURE 21 TOP 10 PATENT APPLICANTS FOR OSTOMY CARE
(JANURAY 2011 TO NOVEMBER 2021) 61
FIGURE 22 PATENTS FOR OSTOMY CARE, BY JURISDICTION
(JANUARY 2011 TO NOVEMBER 2021) 61
5.7 VALUE CHAIN ANALYSIS 62
FIGURE 23 VALUE CHAIN OF THE STOMA/OSTOMY CARE MARKET 62
5.8 PRICING TREND ANALYSIS 63
TABLE 8 AVERAGE PRICE OF STOMA/OSTOMY CARE PRODUCTS,
BY DEVICE NAME, 2020 (USD) 63
5.9 PORTER’S FIVE FORCES ANALYSIS 63
TABLE 9 STOMA/OSTOMY CARE MARKET: PORTER’S FIVE FORCES ANALYSIS 63
5.9.1 THREAT OF NEW ENTRANTS 64
5.9.2 THREAT OF SUBSTITUTES 64
5.9.3 BARGAINING POWER OF SUPPLIERS 65
5.9.4 BARGAINING POWER OF BUYERS 65
5.9.5 INTENSITY OF COMPETITIVE RIVALRY 66
5.10 ECOSYSTEM LANDSCAPE 66
FIGURE 24 STOMA/OSTOMY CARE MARKET: ECOSYSTEM LANDSCAPE 67
6 STOMA/OSTOMY CARE MARKET, BY SURGERY TYPE 68
6.1 INTRODUCTION 69
TABLE 10 STOMA/OSTOMY CARE MARKET, BY SURGERY TYPE,
2019–2026 (USD MILLION) 69
6.2 COLOSTOMY 69
6.2.1 A LARGE NUMBER OF COLOSTOMIES PERFORMED
TO DRIVE MARKET GROWTH 69
TABLE 11 TYPES OF COLOSTOMY BASED ON STOMA LOCATION 69
TABLE 12 STOMA/OSTOMY CARE MARKET FOR COLOSTOMY, BY COUNTRY/REGION, 2019–2026 (USD MILLION) 70
6.3 ILEOSTOMY 71
6.3.1 INCREASING INCIDENCE OF ULCERATIVE COLITIS AND
CROHN’S DISEASE TO SUPPORT MARKET GROWTH 71
TABLE 13 TYPES OF ILEOSTOMY PROCEDURES 71
TABLE 14 STOMA/OSTOMY CARE MARKET FOR ILEOSTOMY, BY COUNTRY/
REGION, 2019–2026 (USD MILLION) 72
6.4 UROSTOMY 73
6.4.1 UROSTOMIES ARE COMMONLY PERFORMED FOR
THE TREATMENT OF BLADDER CANCER 73
TABLE 15 STOMA/OSTOMY CARE MARKET FOR UROSTOMY, BY COUNTRY/REGION, 2019–2026 (USD MILLION) 73
7 STOMA/OSTOMY CARE MARKET, BY PRODUCT 74
7.1 INTRODUCTION 75
TABLE 16 STOMA/OSTOMY CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 75
7.2 OSTOMY BAGS 75
7.2.1 EUROPE IS THE LARGEST MARKET FOR OSTOMY BAGS 75
TABLE 17 OSTOMY BAGS MARKET, BY REGION, 2019–2026 (USD MILLION) 75
7.3 OSTOMY ACCESSORIES 76
TABLE 18 OSTOMY ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION) 76
7.3.1 PASTES & POWDERS 76
7.3.1.1 These products protect the skin and increase the wear
time of ostomy products 76
TABLE 19 PASTES & POWDERS MARKET, BY REGION, 2019–2026 (USD MILLION) 77
7.3.2 CREAMS 77
7.3.2.1 Creams help in adding moisture to dry skin caused due to the application and removal of skin barriers 77
TABLE 20 CREAMS MARKET, BY REGION, 2019–2026 (USD MILLION) 77
7.3.3 CLEANSERS 78
7.3.3.1 Cleansers are designed to clean the skin around the stoma 78
TABLE 21 CLEANSERS MARKET, BY REGION, 2019–2026 (USD MILLION) 78
7.3.4 DEODORANTS 78
7.3.4.1 Deodorants help in reducing odor emanation 78
TABLE 22 DEODORANTS MARKET, BY REGION, 2019–2026 (USD MILLION) 79
7.3.5 STOMA CAPS 79
7.3.5.1 Stoma caps help in living a normal life 79
TABLE 23 STOMA CAPS MARKET, BY REGION, 2019–2026 (USD MILLION) 79
7.3.6 BELTS 80
7.3.6.1 Belts enhance pouching system adhesion 80
TABLE 24 BELTS MARKET, BY REGION, 2019–2026 (USD MILLION) 80
7.3.7 POUCH COVERS 80
7.3.7.1 Pouch cover increases stoma pouch system aesthetics 80
TABLE 25 POUCH COVERS MARKET, BY REGION, 2019–2026 (USD MILLION) 80
7.3.8 TAPES 81
7.3.8.1 Tapes help in increasing the adhesion of the skin barrier 81
TABLE 26 TAPES MARKET, BY REGION, 2019–2026 (USD MILLION) 81
7.3.9 SEALS/BARRIER RINGS 81
7.3.9.1 Barrier rings help protect peristomal skin 81
TABLE 27 SEALS/BARRIER RINGS MARKET, BY REGION, 2019–2026 (USD MILLION) 81
7.3.10 POUCH CLOSERS 82
7.3.10.1 Pouch closers form a small segment of the market 82
TABLE 28 POUCH CLOSERS MARKET, BY REGION, 2019–2026 (USD MILLION) 82
8 STOMA/OSTOMY CARE MARKET, BY END USER 83
8.1 INTRODUCTION 84
TABLE 29 STOMA/OSTOMY CARE MARKET, BY END USER, 2019–2026 (USD MILLION) 84
8.2 HOSPITALS & SPECIALTY CLINICS 84
8.2.1 A LARGE NUMBER OF OSTOMY PROCEDURES PERFORMED
IN HOSPITALS IS SUPPORTING THE GROWTH OF THIS SEGMENT 84
TABLE 30 STOMA/OSTOMY CARE MARKET FOR HOSPITALS & SPECIALTY CLINICS,
BY REGION, 2019–2026 (USD MILLION) 85
8.3 HOME CARE SETTINGS 85
8.3.1 HOME CARE SETTINGS ARE THE SECOND-LARGEST END USERS
OF OSTOMY PRODUCTS 85
TABLE 31 STOMA/OSTOMY CARE MARKET FOR HOME CARE SETTINGS,
BY REGION, 2019–2026 (USD MILLION) 86
8.4 AMBULATORY SURGICAL CENTERS 86
8.4.1 AMBULATORY CENTERS PROVIDE SAME-DAY CARE AND ARE FINDING INCREASING PREFERENCE 86
TABLE 32 STOMA/OSTOMY CARE MARKET FOR AMBULATORY SURGICAL CENTERS,
BY REGION, 2019–2026 (USD MILLION) 87

9 STOMA/OSTOMY CARE MARKET, BY REGION 88
9.1 INTRODUCTION 89
FIGURE 25 GEOGRAPHIC SNAPSHOT OF THE STOMA/OSTOMY CARE MARKET 89
TABLE 33 STOMA/OSTOMY CARE MARKET, BY REGION, 2019–2026 (USD MILLION) 89
9.2 EUROPE 90
FIGURE 26 EUROPE: STOMA/OSTOMY CARE MARKET SNAPSHOT 90
TABLE 34 EUROPE: STOMA/OSTOMY CARE MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 91
TABLE 35 EUROPE: STOMA/OSTOMY CARE MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 91
TABLE 36 EUROPE: STOMA/OSTOMY CARE MARKET, BY SURGERY TYPE,
2019–2026 (USD MILLION) 91
TABLE 37 EUROPE: OSTOMY CARE ACCESSORIES MARKET, BY TYPE,
2019–2026 (USD MILLION) 92
TABLE 38 EUROPE: STOMA/OSTOMY CARE MARKET, BY END USER,
2019–2026 (USD MILLION) 92
9.2.1 GERMANY 92
9.2.1.1 Favorable reimbursement scenario to support market growth 92
TABLE 39 GERMANY: STOMA/OSTOMY CARE MARKET, BY SURGERY TYPE,
2019–2026 (USD MILLION) 93
9.2.2 UK 93
9.2.2.1 Rising patient population to support the adoption of ostomy products in the country 93
TABLE 40 UK: STOMA/OSTOMY CARE MARKET, BY SURGERY TYPE,
2019–2026 (USD MILLION) 93
9.2.3 FRANCE 94
9.2.3.1 Growing initiatives by the government to propel market growth 94
TABLE 41 FRANCE: STOMA/OSTOMY CARE MARKET, BY SURGERY TYPE,
2019–2026 (USD MILLION) 94
9.2.4 ITALY 94
9.2.4.1 Initiatives by private and government organizations to raise awareness about ostomy care are driving market growth in Italy 94
TABLE 42 ITALY: STOMA/OSTOMY CARE MARKET, BY SURGERY TYPE,
2019–2026 (USD MILLION) 95
9.2.5 SPAIN 95
9.2.5.1 The growing geriatric population has driven demand for ostomy procedures in Spain 95
TABLE 43 SPAIN: STOMA/OSTOMY CARE MARKET, BY SURGERY TYPE,
2019–2026 (USD MILLION) 95
9.2.6 REST OF EUROPE 96
TABLE 44 ROE: STOMA/OSTOMY CARE MARKET, BY SURGERY TYPE,
2019–2026 (USD MILLION) 96
9.3 NORTH AMERICA 96
TABLE 45 NORTH AMERICA: STOMA/OSTOMY CARE MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 96
TABLE 46 NORTH AMERICA: STOMA/OSTOMY CARE MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 97
TABLE 47 NORTH AMERICA: STOMA/OSTOMY CARE MARKET, BY SURGERY TYPE, 2019–2026 (USD MILLION) 97
TABLE 48 NORTH AMERICA: OSTOMY CARE ACCESSORIES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 98
TABLE 49 NORTH AMERICA: STOMA/OSTOMY CARE MARKET, BY END USER,
2019–2026 (USD MILLION) 98
9.3.1 US 99
9.3.1.1 Favorable reimbursement scenario for ostomy supplies to support market growth in the US 99
TABLE 50 US: STOMA/OSTOMY CARE MARKET, BY SURGERY TYPE,
2019–2026 (USD MILLION) 99
9.3.2 CANADA 99
9.3.2.1 A surge in the incidence of target diseases and favorable government guidelines to support market growth 99
TABLE 51 CANADA: STOMA/OSTOMY CARE MARKET, BY SURGERY TYPE,
2019–2026 (USD MILLION) 100
9.4 ASIA PACIFIC 100
FIGURE 27 ASIA PACIFIC: STOMA/OSTOMY CARE MARKET SNAPSHOT 101
TABLE 52 ASIA PACIFIC: STOMA/OSTOMY CARE MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 102
TABLE 53 ASIA PACIFIC: STOMA/OSTOMY CARE MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 102
TABLE 54 ASIA PACIFIC: STOMA/OSTOMY CARE MARKET, BY SURGERY TYPE,
2019–2026 (USD MILLION) 102
TABLE 55 ASIA PACIFIC: OSTOMY CARE ACCESSORIES MARKET, BY TYPE,
–2026 (USD MILLION) 103
TABLE 56 ASIA PACIFIC: STOMA/OSTOMY CARE MARKET, BY END USER,
2019–2026 (USD MILLION) 103
9.4.1 JAPAN 104
9.4.1.1 Rising number of cancer cases to propel market growth 104
TABLE 57 JAPAN: STOMA/OSTOMY CARE MARKET, BY SURGERY TYPE,
2019–2026 (USD MILLION) 104
9.4.2 CHINA 104
9.4.2.1 Increasing patient pool and government initiatives for healthcare development are fueling the market growth 104
TABLE 58 CHINA: STOMA/OSTOMY CARE MARKET, BY SURGERY TYPE,
2019–2026 (USD MILLION) 105
9.4.3 INDIA 105
9.4.3.1 Rising patient population is propelling the market growth 105
TABLE 59 INDIA: STOMA/OSTOMY CARE MARKET, BY SURGERY TYPE,
2019–2026 (USD MILLION) 105
9.4.4 AUSTRALIA 106
9.4.4.1 Government initiatives to support market growth 106
TABLE 60 AUSTRALIA: STOMA/OSTOMY CARE MARKET, BY SURGERY TYPE
2019–2026 (USD MILLION) 106
9.4.5 SOUTH KOREA 106
9.4.5.1 Increasing R&D activities in the country to drive market growth 106
TABLE 61 SOUTH KOREA: STOMA/OSTOMY CARE MARKET, BY SURGERY TYPE,
2019–2026 (USD MILLION) 107
9.4.6 REST OF APAC 107
TABLE 62 ROAPAC: STOMA/OSTOMY CARE MARKET, BY SURGERY TYPE,
2019–2026 (USD MILLION) 107
9.5 LATIN AMERICA 108
TABLE 63 LATIN AMERICA: STOMA/OSTOMY CARE MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 108
TABLE 64 LATIN AMERICA: STOMA/OSTOMY CARE MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 108
TABLE 65 LATIN AMERICA: STOMA/OSTOMY CARE MARKET, BY SURGERY TYPE,
2019–2026 (USD MILLION) 109
TABLE 66 LATIN AMERICA: OSTOMY CARE ACCESSORIES MARKET, BY TYPE,
2019–2026 (USD MILLION) 109
TABLE 67 LATIN AMERICA: STOMA/OSTOMY CARE MARKET, BY END USER,
2019–2026 (USD MILLION) 110
9.5.1 BRAZIL 110
9.5.1.1 Growing adoption of healthcare insurance in the country to support market growth 110
TABLE 68 BRAZIL: STOMA/OSTOMY CARE MARKET, BY SURGERY TYPE,
2019–2026 (USD MILLION) 110
9.5.2 MEXICO 111
9.5.2.1 Increasing awareness programs are fueling the market growth 111
TABLE 69 MEXICO: STOMA/OSTOMY CARE MARKET, BY SURGERY TYPE,
2019–2026 (USD MILLION) 111
9.5.3 REST OF LATIN AMERICA 111
TABLE 70 ROLA: STOMA/OSTOMY CARE MARKET, BY SURGERY TYPE,
2019–2026 (USD MILLION) 112
9.6 MIDDLE EAST & AFRICA 112
9.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE AND INCREASING PUBLIC-PRIVATE INVESTMENTS TO DRIVE MARKET GROWTH IN THE MEA 112
TABLE 71 MEA: STOMA/OSTOMY CARE MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 112
TABLE 72 MEA: STOMA/OSTOMY CARE MARKET, BY SURGERY TYPE,
2019–2026 (USD MILLION) 113
TABLE 73 MEA: OSTOMY CARE ACCESSORIES MARKET, BY TYPE,
2019–2026 (USD MILLION) 113
TABLE 74 MEA: STOMA/OSTOMY CARE MARKET, BY END USER,
2019–2026(USD MILLION) 114

10 COMPETITIVE LANDSCAPE 115
10.1 INTRODUCTION 115
FIGURE 28 KEY DEVELOPMENTS BY LEADING PLAYERS IN
THE STOMA/OSTOMY CARE MARKET, 2018–2021 115
10.2 REVENUE SHARE ANALYSIS 116
FIGURE 29 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS
IN THE STOMA/OSTOMY CARE MARKET 116
10.3 MARKET SHARE ANALYSIS 117
FIGURE 30 STOMA/OSTOMY CARE MARKET SHARE, BY KEY PLAYER, 2020 117
10.4 COMPETITIVE LEADERSHIP MAPPING: COMPANY EVALUATION QUADRANT (2020) 118
10.4.1 STARS 118
10.4.2 EMERGING LEADERS 119
10.4.3 PERVASIVE PLAYERS 119
10.4.4 PARTICIPANTS 119
FIGURE 31 STOMA/OSTOMY CARE MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020 119
10.5 COMPETITIVE LEADERSHIP MAPPING: START-UP/SME EVALUATION
QUADRANT (AS OF 2020) 120
10.5.1 PROGRESSIVE COMPANIES 120
10.5.2 RESPONSIVE COMPANIES 120
10.5.3 DYNAMIC COMPANIES 120
10.5.4 STARTING BLOCKS 120
FIGURE 32 STOMA/OSTOMY CARE MARKET: COMPETITIVE
LEADERSHIP MAPPING (SMES/START-UPS) 121
10.6 COMPETITIVE BENCHMARKING 122
TABLE 75 PRODUCT FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE STOMA/OSTOMY CARE MARKET 122
TABLE 76 COMPANY FOOTPRINT ANALYSIS IN THE STOMA/OSTOMY CARE MARKET 123
10.7 COMPETITIVE SCENARIO (2018–2021) 124
10.7.1 PRODUCT LAUNCHES 124
10.7.2 DEALS 125
10.7.3 OTHER DEVELOPMENTS 125
11 COMPANY PROFILES 126
11.1 KEY PLAYERS 126
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 COLOPLAST CORP 126
TABLE 77 COLOPLAST CORP: BUSINESS OVERVIEW 126
FIGURE 33 COLOPLAST CORP: COMPANY SNAPSHOT (2020) 127
11.1.2 CONVATEC 134
TABLE 78 CONVATEC INC.: BUSINESS OVERVIEW 134
FIGURE 34 CONVATEC INC.: COMPANY SNAPSHOT (2020) 135
11.1.3 B. BRAUN MELSUNGEN AG 138
TABLE 79 B. BRAUN MELSUNGEN AG: BUSINESS OVERVIEW 138
FIGURE 35 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2020) 139
11.1.4 HOLLISTER INCORPORATED 142
TABLE 80 HOLLISTER INCORPORATED: BUSINESS OVERVIEW 142
11.1.5 ALCARE CO. LTD. 147
TABLE 81 ALCARE CO. LTD.: BUSINESS OVERVIEW 147
11.1.6 CYMED MICRO SKIN 150
TABLE 82 CYMED MICRO SKIN: BUSINESS OVERVIEW 150
11.1.7 NU-HOPE LABORATORIES, INC. 152
TABLE 83 NU-HOPE LABORATORIES, INC.: BUSINESS OVERVIEW 152
11.1.8 FLEXICARE (GROUP) LIMITED 153
TABLE 84 FLEXICARE (GROUP) LIMITED: BUSINESS OVERVIEW 153
11.1.9 SALTS HEALTHCARE 155
TABLE 85 SALTS HEALTHCARE: BUSINESS OVERVIEW 155
11.1.10 WELLAND MEDICAL LIMITED 157
TABLE 86 WELLAND MEDICAL LIMITED: BUSINESS OVERVIEW 157
11.1.11 3M 161
TABLE 87 3M: BUSINESS OVERVIEW 161
FIGURE 36 3M: COMPANY SNAPSHOT (2020) 162
11.1.12 SMITH & NEPHEW 164
TABLE 88 SMITH & NEPHEW: BUSINESS OVERVIEW 164
FIGURE 37 SMITH & NEPHEW: COMPANY SNAPSHOT (2020) 165
11.1.13 MARLEN MANUFACTURING & DEVELOPMENT COMPANY 166
TABLE 89 MARLEN MANUFACTURING & DEVELOPMENT COMPANY: BUSINESS OVERVIEW 166
11.1.14 TORBOT GROUP INC. 168
TABLE 90 TORBOT GROUP INC: BUSINESS OVERVIEW 168
11.1.15 PERMA-TYPE COMPANY INC. 170
TABLE 91 PERMA-TYPE COMPANY INC.: BUSINESS OVERVIEW 170
11.2 OTHER PLAYERS 173
11.2.1 SCAPA HEALTHCARE 173
TABLE 92 SCAPA HEALTHCARE: BUSINESS OVERVIEW 173
11.2.2 TYTEX A/S 174
TABLE 93 TYTEX A/S: BUSINESS OVERVIEW 174
11.2.3 PROWESS CARE 175
TABLE 94 PROWESS CARE: BUSINESS OVERVIEW 175
11.2.4 SAFE N SIMPLE 176
TABLE 95 SAFE N SIMPLE: BUSINESS OVERVIEW 176
11.2.5 SCHENA OSTOMY TECHNOLOGIES INC. 178
TABLE 96 SCHENA OSTOMY TECHNOLOGIES INC.: BUSINESS OVERVIEW 178
11.2.6 AVITR FARMICA 179
TABLE 97 AVITR FARMICA: BUSINESS OVERVIEW 179
11.2.7 TRIO HEALTHCARE LTD. 180
TABLE 98 TRIO HEALTHCARE LTD.: BUSINESS OVERVIEW 180
11.2.8 CRIMSON HEALTHCARE PVT. LTD. 181
TABLE 99 CRIMSON HEALTHCARE PVT. LTD.: BUSINESS OVERVIEW 181
11.2.9 FORTIS MEDICAL PRODUCTS 182
TABLE 100 FORTIS MEDICAL PRODUCTS: BUSINESS OVERVIEW 182
11.2.10 ANGIPLAST PVT. LTD. 183
TABLE 101 ANGIPLAST PVT. LTD.: BUSINESS OVERVIEW 183
11.2.11 OAKMED HEALTHCARE 184
TABLE 102 OAKMED HEALTHCARE: BUSINESS OVERVIEW 184
11.2.12 WUJIANG EVERGREEN EX/IM CO. LTD. 188
TABLE 103 WUJIANG EVERGREEN EX/IM CO. LTD.: BUSINESS OVERVIEW 188
11.2.13 ZHEJIANG AILEBAO MEDICAL TECHNOLOGIES CO. LTD. 189
TABLE 104 ZHEJIANG AILEBAO MEDICAL TECHNOLOGIES CO. LTD.: BUSINESS OVERVIEW 189
11.2.14 EAKIN HEALTHCARE GROUP 190
TABLE 105 EAKIN HEALTHCARE GROUP: BUSINESS OVERVIEW 190
11.2.15 POLARSEAL 192
TABLE 106 POLARSEAL: BUSINESS OVERVIEW 192
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX 193
12.1 DISCUSSION GUIDE 193
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 197
12.3 AVAILABLE CUSTOMIZATIONS 199
12.4 RELATED REPORTS 199
12.5 AUTHOR DETAILS 200


お問合せフォーム

    • 리포트 제목은 자동으로 입력됩니다.
    • *항목은 필수항목입니다.

    의뢰분류*

    성함*

    회사명*

    부서명

    이메일*

    전화번호

    저희 사이트를 알게 된 경로를 가르쳐 주세요.

    문의 내용*

     

    ※개인정보보호정책은여기에서 확인 가능합니다。

    Email 문의도 받고 있습니다.
    아래 주소이며 죄송하지만 "(at)"을 "@"로 바꾸어 보내주시길 부탁드립니다.
    mooneui(at)chosareport-korea.com